You may also like these news :
Knives Come Out on Stem Cell Bill
State-funded stem cell research could solve medical mysteries, but California's efforts to secure affordable access to any resulting drugs -- and a cut of any profits -- are only raising "what-ifs" for bioscience firms. Attorneys say current legislation staking a state claim to $3 billion in future bond-funded stem cell research is vulnerable to challenge. And their clients, some of the state's largest bioscience companies, don't like the bill's proposed 25 percent state take on net licensing revenues.